Previous studies on COVID-19-positive patients reported mixed results, with SOD levels identified as decreased by Liao et al. [41], while other studies reported increased SOD levels, associated with increased CAT and GPx levels [23,42], concurring with our findings. This evidence concerns the gene SOD1 and COVID-19.